A Phase II Efficacy and Safety, Open-Label, Multicenter Study of Imprime PGG Injection in Combination With Cetuximab in Patients With Stage IV KRAS-Mutant Colorectal Cancer - Concepedia

Concepedia

Publication | Open Access

A Phase II Efficacy and Safety, Open-Label, Multicenter Study of Imprime PGG Injection in Combination With Cetuximab in Patients With Stage IV KRAS-Mutant Colorectal Cancer

DOI Full Paper Access

43

Citations

18

References

2016

Year

Neil H. Segal, Purvi Gada, Neil Senzer, Michele Gargano, Myra L. Patchen, Leonard B. Saltz

Clinical Colorectal Cancer

MedicinePhase Ii EfficacyColorectal CancerPathologyCancer TreatmentMulticenter StudyOncologyRadiation OncologyCancer ResearchImprime Pgg Injection

References

	Year	Citations

Page 1